BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6169181)

  • 1. Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Nozumi K; Sato R; Ito H; Maruoka M; Shimazaki J
    Urol Int; 1981; 36(2):79-87. PubMed ID: 6169181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Shimazaki J; Hikage T; Sato R; Kodama T; Ito H
    Endocrinol Jpn; 1981 Dec; 28(6):725-34. PubMed ID: 6179768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androphilic proteins in the human prostate.
    Shimazaki J; Ito H; Kodama T; Nozumi K; Maruoka M; Wakisaka M; Naito H; Miyauchi T; Matsumura T; Sato R
    Prostate Suppl; 1981; 1():9-17. PubMed ID: 6176984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of progestin-binding protein in benign hypertrophic human prostate.
    Akimoto S; Sato R; Kodama T; Zama S; Fuse H; Shimazaki J
    Endocrinol Jpn; 1986 Jun; 33(3):423-32. PubMed ID: 2428606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 16 beta-ethyl-17 beta-hydroxy-4-estren-3-one (TSAA-291) on the binding of promegestone (R5020) and methyltrienolone (R1881) to hyperplastic and neoplastic human prostate.
    Bashirelahi N; Ganesan S; Ekiko DB; Young JD; Shida K; Yamanaka H; Takahashi E
    J Steroid Biochem; 1986 Sep; 25(3):367-74. PubMed ID: 2430141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrotestosterone-binding protein in cytosols of normal and hypertrophic human prostates, and influence of estrogens and anti-androgens on the binding.
    Shimazaki J; Kodama T; Wakisaka M; Katayama T
    Endocrinol Jpn; 1977 Feb; 24(1):9-14. PubMed ID: 67940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of androgen receptors in human benign prostatic hypertrophy with two synthetic radiolabeled ligands.
    Schwemmer B; Böttger I; Schiessl J; Reidel G; Schütz W
    Urol Int; 1986; 41(2):133-8. PubMed ID: 2425471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.
    Rowley DR; Thompson SA; Lubaroff DM; Heidger PM
    Prostate; 1984; 5(1):101-11. PubMed ID: 6607463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of androgen binding sites by exchange with methyltrienolone (R 1881).
    Bonne C; Raynaud JP
    Steroids; 1976 Apr; 27(4):497-507. PubMed ID: 58452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid receptor content in cytosol from normal and hyperplastic human prostates.
    Ekman P; Snochowski M; Dahlberg E; Bression D; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1979 Aug; 49(2):205-15. PubMed ID: 88456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor content of normal and hyperplastic human prostate.
    Trachtenberg J; Bujnovszky P; Walsh PC
    J Clin Endocrinol Metab; 1982 Jan; 54(1):17-21. PubMed ID: 6172440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the androgen binding in human benign prostatic hypertrophy.
    Nijs M; Coune A
    J Recept Res; 1989; 9(3):271-95. PubMed ID: 2475625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881.
    Akimoto S; Fuse H; Sato R; Zama S; Shimazaki J
    Endocrinol Jpn; 1985 Feb; 32(1):141-52. PubMed ID: 2410244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
    Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
    J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding to R 1881 (methyltrienolone) of proteins from human benign prostatic hypertrophy.
    Kodama T; Hasebe C; Shimazaki J
    Endocrinol Jpn; 1980 Apr; 27(2):229-37. PubMed ID: 6157523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor content of the normal and hyperplastic canine prostate.
    Shain SA; Boesel RW
    J Clin Invest; 1978 Mar; 61(3):654-60. PubMed ID: 76635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative binding specificity of methyltrienolone in human and rat prostate.
    Dubé JY; Chapdelaine P; Tremblay RR; Bonne C; Raynaud JP
    Horm Res; 1976; 7(6):341-7. PubMed ID: 69599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor proteins for androgens in prostatic disease.
    Ghanadian R; Auf G; Chisholm GD; O'Donoghue EP
    Br J Urol; 1978 Dec; 50(7):567-9. PubMed ID: 88985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.